Procter & Gamble Health Ltd
PGHLProcter & Gamble Health Ltd
PGHL
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 35.90 | 11.06 | 1.23% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.48 | 5.11 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 962.81 | 1,016.97 | 772.07 | 1,616.92 | — | 1,424.75 | 1,026.83 | 1,127.60 | 1,248.01 | 1,258.02 | ||||||||||
Raw Materials | 436.87 | 413.32 | 222.95 | 272.83 | — | 444.47 | 310.39 | 344.55 | 358.99 | 914.48 | ||||||||||
| Power & Fuel Cost | 15.14 | 14.96 | 11.68 | 12.23 | 19.09 | 12.97 | 14.70 | 12.88 | ||||||||||||
| Employee Cost | 123.17 | 154.23 | 109.88 | 131.27 | 182.93 | 153.66 | 167.56 | 206.17 | ||||||||||||
| Selling & Administrative Expenses | 226.39 | 237.59 | 188.49 | 192.98 | 257.28 | 173.99 | 203.91 | 196.86 | ||||||||||||
| Operating & Other expenses | 54.49 | 56.89 | 88.16 | 91.53 | 136.68 | 111.70 | 116.01 | 130.04 | ||||||||||||
EBITDA | 106.75 | 139.98 | 150.91 | 916.08 | — | 384.30 | 264.12 | 280.87 | 343.07 | 343.54 | ||||||||||
| Depreciation/Amortization | 23.42 | 24.81 | 19.12 | 21.12 | — | 29.45 | 30.04 | 27.08 | 28.10 | 27.10 | ||||||||||
| PBIT | 83.33 | 115.17 | 131.79 | 894.96 | — | 354.85 | 234.08 | 253.79 | 314.97 | 316.44 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.80 | 0.42 | 0.77 | 0.79 | ||||||||||
| PBT | 83.33 | 115.17 | 131.79 | 894.96 | — | 354.85 | 233.28 | 253.37 | 314.20 | 315.65 | ||||||||||
| Taxes & Other Items | 29.77 | 36.04 | 37.88 | 56.24 | — | 100.77 | 56.48 | 60.85 | 84.73 | 84.27 | ||||||||||
| Net Income | 53.56 | 79.13 | 93.91 | 838.72 | — | 254.08 | 176.80 | 192.52 | 229.47 | 231.38 | ||||||||||
| EPS | 32.27 | 47.67 | 56.57 | 505.27 | — | 153.07 | 106.51 | 115.98 | 138.24 | 139.39 | ||||||||||
| DPS | 7.50 | 11.00 | 15.00 | 440.00 | — | 230.00 | 130.00 | 52.50 | 61.50 | 56.50 | ||||||||||
| Payout ratio | 0.23 | 0.23 | 0.27 | 0.87 | — | 1.50 | 1.22 | 0.45 | 0.44 | 0.41 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Procter & Gamble Health Ltd | 36.20 | 11.06 | 1.23% |
| Sun Pharmaceutical Industries Ltd | 35.09 | 5.01 | 0.93% |
| Cipla Ltd | 35.23 | 4.16 | 0.69% |
| Dr Reddy's Laboratories Ltd | 21.37 | 4.14 | 0.69% |
Price Comparison
Compare PGHL with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Procter & Gamble Health Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Nippon India SMALL CAP FUND DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 3.3527% | Percentage of the fund’s portfolio invested in the stock 0.75% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 65/215 (0) |
HDFC Small Cap Fund - Direct Plan - Growth Option Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.8413% | Percentage of the fund’s portfolio invested in the stock 0.66% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 29/79 (+2) |
DSP Healthcare Fund - Direct - Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.9799% | Percentage of the fund’s portfolio invested in the stock 4.23% | Change in the portfolio weight of the stock over the last 3 months -0.47% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/29 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateNov 23, 2023
Dividend/Share
₹50.00
Ex DateEx Date
Nov 23, 2023
Cash Dividend
Ex DateEx DateFeb 13, 2023
Dividend/Share
₹45.00
Ex DateEx Date
Feb 13, 2023
Cash Dividend
Ex DateEx DateNov 15, 2022
Dividend/Share
₹11.50
Ex DateEx Date
Nov 15, 2022
Cash Dividend
Ex DateEx DateMay 12, 2022
Dividend/Share
₹41.00
Ex DateEx Date
May 12, 2022
Cash Dividend
Ex DateEx DateNov 2, 2021
Dividend/Share
₹40.00
Ex DateEx Date
Nov 2, 2021
News & Opinions
Procter & Gamble Health share price falls 5% on weak Q4 results
3 months ago•Moneycontrol
Procter & Gamble Health appoints Lokesh Chandak as CFO
8 months ago•The Hindu Businessline
Trade Spotlight | Your blueprint for Procter & Gamble Health, M&M Financial Services, Zydus Lifesciences today
10 months ago•Moneycontrol
Procter & Gamble Health shares surge 15% today amid heavy volumes
10 months ago•Business Today
Volumes jump at Procter & Gamble Health Ltd counter
10 months ago•Business Standard
Procter & Gamble Health shares spike 13% on 71% surge in profit
10 months ago•Moneycontrol
Vodafone Idea Ltd leads gainers in ‘A’ group
10 months ago•Business Standard
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -5.05%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.8% to 0.39%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -22.83%, vs industry avg of 9.82%